Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke

Stroke

Volumn 45, Issue 10, 2014, Pages 3008-3018

  Lees, Rosalind ^a   Selvarajah, Johann ^a   Fenton, Candida ^a   Pendlebury, Sarah T ^b   Langhorne, Peter ^a   Stott, David J ^a   Quinn, Terence J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

cognitive impairment; dementia; sensitivity; specificity; stroke

Indexed keywords

ADDENBROOKE COGNITIVE EXAMINATION REVISED; ARTICLE; CEREBROVASCULAR ACCIDENT; COGNITION ASSESSMENT; COGNITIVE DEFECT; COGNITIVE SCREENING TEST; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EXECUTIVE FUNCTION; HUMAN; META ANALYSIS; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MULTIDOMAIN COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL BATTERY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; AGED; COGNITION DISORDERS; COMPLICATION; PSYCHOLOGY;

AGED; COGNITION DISORDERS; DEMENTIA; HUMANS; NEUROPSYCHOLOGICAL TESTS; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84922481581     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005842     Document Type: Article

References (59)

1. Pendlebury ST, Wadling S, Silver LE, Mehta Z, Rothwell PM. Transient cognitive impairment in TIA and minor stroke. Stroke. 2011;42:3116-3121.
2. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurol. 2009;8:1006-1018.
3. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4:752-759.
4. Pollock A, St George B, Fenton M, Firkins L. Top ten research priorities relating to life after stroke. Lancet Neurol. 2012;11:209.
5. Chodosh J, Petitti DB, Elliott M, Hays RD, Crooks VC, Reuben DB, et al. Physician recognition of cognitive impairment: evaluating the need for improvement. J Am Geriatr Soc. 2004;52:1051-1059.
6. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241.
7. Royal College of Physicians. National Clinical Guidelines for Stroke Clinical. Effectiveness and Evaluation Unit. London Royal College of Physicians; 2012.
8. SIGN Guideline 118. Management of patients with stroke. Rehabilitation, prevention and management of complications and discharge planning Scottish Intercollegiate Guidelines Network (SIGN); 2010
9. Lees R, Fearon P, Harrison JK, Broomfield NM, Quinn TJ. Cognitive and mood assessment in stroke research: focused review of contemporary studies. Stroke. 2012;43:1678-1680.
10. Lees RA, Broomfield NM, Quinn TJ. Questionnaire assessment of usual practice in mood and cognitive assessment in Scottish stroke units. Disabil Rehabil. 2014;36:339-343.
11. Hénon H, Lebert F, Durieu I, Godefroy O, Lucas C, Pasquier F, et al. Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke. 1999;30:773-779.
12. Shi Q, Presutti R, Selchen D, Saposnik G. Delirium in acute stroke: A systematic review and meta-analysis. Stroke. 2012;43:645-649.
13. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 0. 2. The Cochrane Collaboration; 2009.
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology. JAMA. 2000; 283:2008-2012.
15. Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. Impact of different operational definitions on mild cognitive impairment rate and MMSE and MoCA performance in transient ischaemic attack and stroke. Cerebrovasc Dis. 2013;36:355-362.
16. Noel-Storr AH, McCleery JM, Richard E, Ritchie CW, Flicker L, Cullum S, et al. Reporting standards for studies of diagnostic test accuracy in dementia. Neurology. 2014;83:364-373.
17. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al; QUADAS-2 Group. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-536.
18. Davis DHJ, Creavin ST, Noel-Storr A, Quinn TJ, Smailagic N, Hyde C, et al. Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: A generic protocol for crosssectional and delayed-verification studies. Cochrane Database Syst Rev. 2013;3:CD010460.
19. Takwoingi Y, Deeks JJ. MetaDAS: A SAS macro for meta-analysis of diagnostic accuracy studies. User Guide Version 1. 3. http://srdta. cochrane. org/. Accessed January 2014.
20. Mitchell AJ. SensitivityxPPV is a recognized test called the clinical utility index. Eur J Epidemiol. 2011;26:251-252.
21. Salvadori E, Pasi M, Poggesi A, Chiti G, Inzitari D, Pantoni L. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol. 2013;260:2220-2227.
22. Cumming TB, Blomstrand C, Bernhardt J, Linden T. The NIH stroke scale can establish cognitive function after stroke. Cerebrovasc Dis. 2010;30:7-14.
23. Godefroy O, Fickl A, Roussel M, Auribault C, Burnicourt JM, Lamy C, et al. Is the Montreal cognitive assessment superior to the minimental state examination to detect poststroke cognitive impairment? Stroke. 2011;42:1712-1716.
24. Srikanth V, Thrift AG, Fryer JL, Saling MM, Dewey HM, Sturm JW, et al. The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke. Int Psychogeriatr. 2006;18:295-305.
25. Wolf TJ, Stift S, Connor LT, Baum C. Feasibility of using the EFPT to detect executive function deficits at the acute stage of stroke. Stroke. 2010;36:405-412.
26. Baum CM, Connor LT, Morrison T, Hahn M, Dromerick AW, Edwards DF. Reliability, validity, and clinical utility of the Executive Function Performance Test: A measure of executive function in a sample of people with stroke. Am J Occup Ther. 2008;62:446-455.
27. Green S, Sinclair E, Rodgers E, Birks E, Lincoln N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) for post stroke cognitive impairment screening. Int J Ther Rehab. 2013;20:7.
28. Larson E, Kirschner K, Bode R, Heinemann A, Goodman R. Construct and predictive validity of the repeatable battery for the assessment of neuropsychological status in the evaluation of stroke patients. J Clin Exp Neuropsychol. 2005;27:16-32.
29. Desmond DW, Tatemichi TK, Hanzawa L. The telephone interview for cognitive status. Reliability and validity in a stroke sample. Int J Geriat Psychiat. 1994;9:803-807.
30. Pendlebury ST, Welch SJ, Cuthbertson FC, Mariz J, Mehta Z, Rothwell PM. Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-to-face Montreal Cognitive Assessment and neuropsychological battery. Stroke. 2013;44:227-229.
31. Agrell B, Dehlin O. Mini mental state examination in geriatric stroke patients. Validity, differences between subgroups of patients, and relationships to somatic and mental variables. Aging (Milano). 2000;12:439-444.
32. Blake H, McKinney M, Treece K, Lee E, Lincoln NB. An evaluation of screening measures for cognitive impairment after stroke. Age Ageing. 2002;31:451-456.
33. Bour A, Rasquin S, Boreas A, Limburg M, Verhey F. How predictive is the MMSE for cognitive performance after stroke? J Neurol. 2010;257:630-637.
34. Brookes RL, Hannesdottir K, Lawrence R, Morris RG, Markus HS. Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease. Age Ageing. 2012;41:212-218.
35. Cartoni A, Lincoln NB. The sensitivity and specificity of the middlesex elderly assessment of mental state (MEAMS) for detecting cognitive impairment after stroke. Neuropsychol Rehabil. 2005;15:55-67.
36. Cumming TB, Churilov L, Linden T, Bernhardt J. Montreal cognitive assessment and mini-mental state examination are both valid cognitive tools in stroke. Acta Neurol Scand. 2013;128:122-129.
37. de Koning I, Dippel DW, van Kooten F, Koudstaal PJ. A short screening instrument for poststroke dementia: The R-CAMCOG. Stroke. 2000;31:1502-1508.
38. de Koning I, van Kooten F, Koudstaal PJ, Dippel DW. Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia. J Neurol Neurosurg Psychiatry. 2005;76:263-265.
39. Dong Y, Venketasubramanian N, Chan BP, Sharma VK, Slavin MJ, Collinson SL, et al. Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke. J Neurol Neurosurg Psychiatry. 2012;83:580-585.
40. Dong YH, Sharma VK, Chan BPL, Venketasubramanian N, Teoh HL, Seet RC, et al. The Montreal cognitive assessment (MoCA) is superior to the mini-mental state examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurolog Sci. 2010;299:15-18.
41. Grace J, Nadler JD, White DA, Guilmette TJ, Giuliano AJ, Monsch AU, et al. Folstein vs modified Mini-Mental State Examination in geriatric stroke. Stability, validity, and screening utility. Arch Neurol. 1995;52:477-484.
42. Hershey LA, Jaffe DF, Greenough PG, Yang SL. Validation of cognitive and functional assessment instruments in vascular dementia. Int J Psychiatry Med. 1987;17:183-192.
43. Hobson JP, Leeds L, Meara RJ. The feasibility of cognitive screening of patients with ischaemic stroke using the preliminary neuropsychological battery. Psychol Health. 2003;18:655-665.
44. Jodzio K, Biechowska D. Wisconsin card sorting test as a measure of executive function impairments in stroke patients. Appl Neuropsychol. 2010;17:267-277.
45. Morris K, Hacker V, Lincoln NB. The validity of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in acute stroke. Disabil Rehabil. 2012;34:189-195.
46. Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. MoCA, ACER, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke. 2012;43:464-469.
47. Tang WK, Mok V, Chan SS, Chiu HF, Wong KS, Kwok TC, et al. Screening of dementia in stroke patients with lacunar infarcts: comparison of the mattis dementia rating scale and the mini-mental state examination. J Geriatr Psychiatry Neurol. 2005;18:3-7.
48. Wong A, Xiong YY, Kwan PW, Chan AY, Lam WW, Wang K, et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord. 2009;28:81-87.
49. Wu Y, Wang M, Ren M, Xu W. The effects of educational background on Montreal Cognitive Assessment screening for vascular cognitive impairment, no dementia, caused by ischemic stroke. J Clin Neurosci. 2013;20:1406-1410.
50. Nys GM, van Zandvoort MJ, de Kort PL, Jansen BP, Kappelle LJ, de Haan EH. Restrictions of the Mini-Mental State Examination in acute stroke. Arch Clin Neuropsychol. 2005;20:623-629.
51. Nøkleby K, Boland E, Bergersen H, Schanke AK, Farner L, Wagle J, et al. Screening for cognitive deficits after stroke: A comparison of three screening tools. Clin Rehabil. 2008;22:1095-1104.
52. de Koning I, van Kooten F, Dippel DWJ, van Harskamp F, Grobbee DE, Kluft C, Koudstaal PJ. Stroke. The CAMCOG: A useful screening instrument for dementia in stroke patients. Stroke. 1998:29:2080-2086.
53. Johnson-Greene D, Touradji P, Emmerson LC. The Three Cities Test: preliminary validation of a short bedside memory test in persons with acute stroke. Top Stroke Rehabil. 2009;16:321-329.
54. Lees R, Corbet S, Johnston C, Moffitt E, Shaw G, Quinn TJ. Test accuracy of short screening tests for diagnosis of delirium or cognitive impairment in an acute stroke unit setting. Stroke. 2013;44:3078-3083.
55. Wong A, Mok VC, Yim P, Fu M, Lam WW, Yau C, et al. The executive clock drawing task (CLOX) is a poor screening test for executive dysfunction in Chinese elderly patients with subcortical ischemic vascular disease. J Clin Neurosci. 2004;11:493-497.
56. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: A population-based study. Stroke. 2010;41:1290-1293.
57. Schuetz GM, Schlattmann P, Dewey M. Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests. BMJ. 2012;345:e6717
58. Quinn TJ, Fearon P, Noel-Storr AH, Young C, McShane R, Stott DJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev. 2014;4:CD010079.
59. Blackburn DJ, Bafadhel L, Randall M, Harkness KA. Cognitive screening in the acute stroke setting. Age Ageing. 2013;42:113-116.